Mitch Lowe seems to be attracted to scammy OTC companies. He was recently appointed as a director to NTEK, a company subject to recent pump and dump activity. The NTEK appointment resulted in a short lived price increase, but within the week the stock was below the pre appointment price and had resumed its decline. Past performance is no guarantee ....